Clinical Study

In Vivo MRI Tracking of Mesenchymal Stromal Cells Labeled with Ultrasmall Paramagnetic Iron Oxide Particles after Intramyocardial Transplantation in Patients with Chronic Ischemic Heart Disease

Figure 2

Difference in clinical symptoms and quality of life. Difference in angina symptoms (CCS class), shortness of breath symptoms (NYHA class), and quality of life score (SAQ) from baseline to 6 months after treatment. Bar values are mean deviation (SD). CCS = Canadian Cardiovascular Society; NYHA = New York Heart Association; SAQ = Seattle Angina Questionnaire.